Menu Menu

SAGE    Sage Therapeutics Inc    1597553    
Income Statement
Revenue 11,871,000
Net Income -93,551,000
Profit Margin -788.06%

Balance Sheet
Current Assets 604,987,000
Assets 622,432,000
Current Liabilities 60,406,000
Liabilities 70,597,000
Equity 551,835,000

Cash Flow Statement
Operating Cash Flow -200,634,000
Investing Cash Flow 220,104,000

Market Analysis
Price 7.08
BVPS 31.02
PB 0.23
PS 0.41
FCF 19,470,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/14 -0.55
Apr May Jun
4/25 -1.80
Jul Aug Sep
7/31 -1.70
Oct Nov Dec
10/29

Find a discrepancy? The most accurate way to find company fundamental data is to view SAGE documents filed with the SEC.


SAGE Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: